DDAH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.908400E-01
Normal-vs-Stage2
1.514180E-01
Normal-vs-Stage3
7.275400E-01
Normal-vs-Stage4
1.215180E-01
Stage1-vs-Stage2
9.376000E-01
Stage1-vs-Stage3
3.241200E-01
Stage1-vs-Stage4
5.261800E-01
Stage2-vs-Stage3
1.914830E-01
Stage2-vs-Stage4
2.935600E-01
Stage3-vs-Stage4
1.102170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.811180E-01
Normal-vs-AfricanAmerican
1.744400E-01
Normal-vs-Asian
1.745610E-01
Caucasian-vs-AfricanAmerican
2.973600E-01
Caucasian-vs-Asian
3.324200E-01
AfricanAmerican-vs-Asian
4.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.960970E-01
Normal-vs-Female
1.573190E-01
Male-vs-Female
4.284000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.599800E-01
Normal-vs-Age(41-60Yrs)
1.289150E-01
Normal-vs-Age(61-80Yrs)
2.058800E-01
Normal-vs-Age(81-100Yrs)
2.447200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.913200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.421400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.711800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.314810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.423600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.810800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.325560E-01
Normal-vs-Daily Drinker
3.930200E-01
Normal-vs-Weekly Drinker
1.942370E-01
Normal-vs-Occasional Drinker
1.835230E-01
Normal-vs-Social Drinker
1.532180E-01
Non Drinker-vs-Daily Drinker
5.898800E-01
Non Drinker-vs-Weekly Drinker
4.124400E-01
Non Drinker-vs-Occasional Drinker
8.460200E-01
Non Drinker-vs-Social Drinker
9.173600E-01
Daily Drinker-vs-Weekly Drinker
8.549800E-01
Daily Drinker-vs-Occasional Drinker
5.602400E-01
Daily Drinker-vs-Social Drinker
6.159800E-01
Weekly Drinker-vs-Occasional Drinker
3.969400E-01
Weekly Drinker-vs-Social Drinker
4.128600E-01
Occasional Drinker-vs-Social Drinker
9.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.397600E-01
Normal-vs-Grade 2
1.083570E-01
Normal-vs-Grade 3
1.052180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.860200E-01
Grade 1-vs-Grade 3
9.623200E-01
Grade 1-vs-Grade 4
2.397600E-01
Grade 2-vs-Grade 3
2.974200E-01
Grade 2-vs-Grade 4
1.083570E-01
Grade 3-vs-Grade 4
1.052180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.261800E-01
Normal-vs-NonDiabetic
1.526370E-01
Diabetic-vs-NonDiabetic
1.208180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.861400E-01
Normal-vs-NoPancreatitis
1.702180E-01
Pancreatitis-vs-NoPancreatitis
6.819200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.644200E-01
Normal-vs-N1
1.300400E-01
N0-vs-N1
3.344200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.061020E-01
Normal-vs-TP53-NonMutant
1.476200E-01
TP53-Mutant-vs-TP53-NonMutant
6.277400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
